Meenakshi Kamaraj

Meenakshi Kamaraj

Auto-generated profile, based on publicly available information

Meenakshi Kamaraj

Department of Bioengineering, Indian Institute of Science, Bangalore, Karnataka, 560012, India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2023 in Trends in Biotechnology
Verified
Journal Article
Closed access
MKMeenakshi Kamaraj
Meenakshi Kamaraj
NMNafiseh Moghimi
Nafiseh Moghimi
JCJunjie Chen
Junjie Chen
RMRamon Morales
Ramon Morales
SCSHIXUAN CHEN
SHIXUAN CHEN
Johnson V. JohnJohnson V. John
Johnson V. John

11 May 2022 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
MKMeenakshi Kamaraj
Meenakshi Kamaraj
URUday Kiran Roopavath
Uday Kiran Roopavath
PGPravin Shankar Giri
Pravin Shankar Giri
NPNandha Kumar Ponnusamy
Nandha Kumar Ponnusamy
SRSubha Narayan Rath
Subha Narayan Rath

4 August 2025 in Biofabrication
Verified
Journal Article
Open access
PDF file
MKMeenakshi Kamaraj
Meenakshi Kamaraj
LALilith Mabel Caballero Aguilar
Lilith Mabel Caballero Aguilar
SDSerena Duchi
Serena Duchi
SDStephanie Doyle
Stephanie Doyle
SRSubha Narayan Rath
Subha Narayan Rath
OCOnofrillo Carmine
Onofrillo Carmine
This study addresses the challenges of tracking cell-mediated biodegradation in cartilage tissue engineering, where hydrogels and scaffolds play a crucial role in providing structural support and promoting tissue regeneration. This research area has been rarely studied, offering potential insights into bridging the gap between in vitro and in vivo conditions for real-time monitoring of tissue regeneration alongside biodegradation. We developed dual-labeled hydrogel/scaffold composites for real-time monitoring of scaffold degradation in response to cell activity. Gelatin methacryloyl (GelMA) hydrogels are extensively explored for cartilage tissue engineering, albeit concerns remain regarding their mechanical properties under load-bearing conditions. To address this, a hydrogel/scaffold composite system was employed in this study, where a poly (ϵ-caprolactone) (PCL) hex prism edge structure acts as a scaffold to support the cell-laden GelMA hydrogel. Fluorophore labeling of GelMA and PCL facilitated non-invasive monitoring of the hydrogel/scaffold composite biodegradation under cell proliferation conditions. Initially, the behavior of fluorescent-tagged Hydrogel/Scaffold was examined under accelerated degradation conditions. Subsequently, human adipose-derived mesenchymal stem cells loaded into fluorescent-labeled hydrogel/scaffolds were evaluated for their biocompatibility potential and chondrogenesis. Results demonstrated a correlation between the loss of fluorescence from the hydrogel/scaffold degradation, accompanied by extracellular matrix accumulation. The fluorescently labeled hydrogel/scaffold holds promising application for cartilage tissue engineering, offering the capability to monitor biodegradation using high-throughput and contactless techniques.

8 December 2023 in ACS Applied Polymer Materials
Verified
Journal Article
Closed access
MKMeenakshi Kamaraj
Meenakshi Kamaraj
ADAmrutha Datla
Amrutha Datla
SMSimon E. Moulton
Simon E. Moulton
SRSubha Narayan Rath
Subha Narayan Rath

24 October 2023 in Journal of Applied Polymer Science
Verified
Journal Article
Open access
EBEmily Balaburov
Emily Balaburov
MKMeenakshi Kamaraj
Meenakshi Kamaraj
SDStephanie E. Doyle
Stephanie E. Doyle
ZAZarrin Ahmadi
Zarrin Ahmadi
CBClaudia Di Bella
Claudia Di Bella
LALilith M. Caballero Aguilar
Lilith M. Caballero Aguilar
The nondestructive localization and traceability of polymers by fluorescent tagging has become a valuable tool for biomedical applications. Integration of fluorescent molecule to the pristine polymers could modify polymers' degradation rate which is still unpredictable from a scaffold application standpoint. The current study focused to understand the material perspective of fluorescently tagged biodegradable polymers such as polycaprolactone (PCL) and poly (d,l‐lactide‐co‐glycolide) (PLGA) with fluorescein amine isomer I (FITC). PCL‐FITC and PLGA‐FITC were characterized using FTIR for surface chemistry analysis and rheology for their mechanical properties. The grafted materials were utilized to form 3‐dimentional scaffolds, and their degradation was monitored under accelerated degradation conditions triggered by pH. It was found that PCL and PCL‐FITC had a very slow degradation rate, when compared to PLGA and PLGA‐FITC. Both the FITC tagged materials displayed a faster degradation rate compared to their respective pristine material. Biocompatibility of the FITC conjugated polymers was tested using human‐adipose derived stem cells (hADSCs) revealing that the sub products from the degradation of the polymers over 7 days did not negatively affect the cellular metabolic activity. This work highlights the significance of initial characterization of fluorescent modified polymers for future biomedical application.

9 June 2026 in Materials Today Bio
Verified
Journal Article
Open access
KJKeuna Jeon
Keuna Jeon
UKUijin Kim
Uijin Kim
CJChang-Hun Ji
Chang-Hun Ji
MKMeenakshi Kamaraj
Meenakshi Kamaraj
NLNoah Zachary Laird
Noah Zachary Laird
Natashya FalconeNatashya Falcone
Natashya Falcone
The tumor microenvironment (TME) is a dynamic and heterogeneous ecosystem in which cancer, stromal, immune, and physicochemical components collectively regulate disease progression and therapeutic response. Recent evidence further indicates that intratumoral bacteria are active contributors to tumor metabolism, immune modulation, and treatment outcomes, revealing a previously underexplored multi-kingdom dimension of solid tumors. However, mechanistic understanding of tumor–microbe interactions remain limited by the absence of experimental platforms that integrate microbial components into physiologically relevant and controllable tumor models. Here, we propose bacteria-integrated tumor microenvironments as an emerging bioengineering framework for modeling cancer as a multi-kingdom system with biomaterials. We first lay out the existence of bacteria in our body and outline key design principles for these systems, including control of microbial localization, nutrient and oxygen gradients, and interkingdom signaling within engineered matrices. We further discuss applications in studying microbial contributions to therapeutic resistance, evaluating engineered bacterial therapies, and developing patient-specific tumor–microbiome models for precision oncology. Finally, we highlight challenges in standardizing multi-kingdom tumor platforms and integrating them with advanced imaging, sequencing, and computational tools. Collectively, bacteria-integrated TME establish a new paradigm for engineering cancer as a multi-kingdom system with translational potential in oncology.